Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vasculogenesis in kidney organoids upon transplantation. | NPJ Regen Med | 2022 | 35986027 | PubTator, text mining | PubMed |
| Inhibition of platelet-derived growth factor pathway suppresses tubulointerstitial injury in renal congestion. | J Hypertens | 2022 | 35983805 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. | Int J Biol Sci | 2022 | 35982899 | PubTator, text mining | PubMed |
| In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer. | Transl Cancer Res | 2022 | 35966316 | PubTator, text mining | PubMed |
| Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve. | Ann Cardiothorac Surg | 2022 | 35958528 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-derived smooth muscle cells to study cardiovascular calcification. | Front Cardiovasc Med | 2022 | 35958427 | PubTator, text mining | PubMed |
A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells. | Front Bioeng Biotechnol | 2022 | 35957645 | PubTator, text mining | PubMed |
| The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications. | Int J Mol Sci | 2022 | 35955714 | PubTator, text mining | PubMed |
| The Protective Action of Metformin against Pro-Inflammatory Cytokine-Induced Human Islet Cell Damage and the Mechanisms Involved. | Cells | 2022 | 35954309 | PubTator, text mining | PubMed |
| Clonal diversification and histogenesis of malignant germ cell tumours. | Nat Commun | 2022 | 35953478 | PubTator, text mining | PubMed |
| 3-Arylcoumarin inhibits vascular calcification by inhibiting the generation of AGEs and anti-oxidative stress. | J Enzyme Inhib Med Chem | 2022 | 35950567 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling. | J Am Heart Assoc | 2022 | 35929448 | PubTator, text mining | PubMed |
| A Detailed Overview About the Single-Cell Analyses of Solid Tumors Focusing on Colorectal Cancer. | Pathol Oncol Res | 2022 | 35928965 | PubTator, text mining | PubMed |
| Di-n-butyl phthalate regulates vascular smooth muscle cells phenotypic switching by MiR-139-5p-MYOCD pathways. | Toxicology | 2022 | 35926758 | PubTator, text mining | PubMed |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. | Science | 2022 | 35926050 | PubTator, text mining | PubMed |
| Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors. | Cell Mol Life Sci | 2022 | 35913515 | PubTator, text mining | PubMed |
| Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer. | J Oncol | 2022 | 35909899 | PubTator, text mining | PubMed |
| Metabolomics of clinical samples reveal the treatment mechanism of lanthanum hydroxide on vascular calcification in chronic kidney disease. | Proc Jpn Acad Ser B Phys Biol Sci | 2022 | 35908957 | PubTator, text mining | PubMed |
| Theaflavin-3,3'-Digallate from Black Tea Inhibits Neointima Formation Through Suppression of the PDGFRβ Pathway in Vascular Smooth Muscle Cells. | Front Pharmacol | 2022 | 35903325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=52